Sleep for Health Study on the Effects of Cognitive Behavioral Therapy for Insomnia on Diabetes Risk

Korábbi kezelés

• Received a full course of CBT-I in the last 12 months
• Current use of medication with glycemic effects:
• Unstable sleep medication regimen (recent change to schedule or dosage)

Más betegség

• History of type 1 or type 2 diabetes or recent/planned use of hypoglycemic agents (e.g., metformin, insulin)
• Recent history of bariatric surgery or planning bariatric surgery in the next year
• Unwilling or unable to limit heavy machinery use/long bouts of driving or unstable illness that would be worsened by sleep restriction
• Epilepsy
• Medical conditions that interfere with dCBT-I or contribute to insomnia or diabetes risk (e.g., hyperthyroidism, significant kidney disease, active cancer treatment, any medical condition that requires chronic steroid use)
• Significant alcohol or substance use disorder
• Active or recent history of eating disorder, recent weight change of >10%
• Extensive skin changes or adhesive allergy making CGM sensor use problematic

Egyéb

• BMI > 40 kg/m2
• Sleep comorbidities detected in medical record or via medical history
• Shift work or significant, externally imposed irregular sleep schedule
• moderate to severe OSA by home sleep apnea test as part of trial protocol
• Current or recent use of weight loss meds
• Significant comorbidity that may interfere with CBT-I uptake or increase risks
• High risk of falls
• Women: pregnancy (current or planned), breastfeeding, < 1 year postpartum
• Use of hydroxyurea

• Age ≥ 22 years and < 80 years of age
• Prediabetes
• Insomnia
• Regular access to device with internet access
• Adequate data at baseline